Skip to main content

Day: February 9, 2021

Freddie Mac Announces Release Date for Fourth Quarter and Full-Year 2020 Financial Results

MCLEAN, Va., Feb. 09, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB:FMCC) announced today that it plans to report its fourth quarter and full-year 2020 financial results before the U.S. financial markets open on Thursday, Feb. 11, 2021.The company will hold a call at 9 a.m. Eastern Time (ET) on Thursday, Feb. 11, 2021, to share the company’s results with the media.  The call will be concurrently webcast, and the replay will be available on the company’s website for approximately 30 days.All materials related to the call will be available on the Investor Relations page of the company’s website.Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters in communities...

Continue reading

Computer Modelling Group Announces Third Quarter Results

CALGARY, Alberta, Feb. 09, 2021 (GLOBE NEWSWIRE) — Computer Modelling Group Ltd. (“CMG” or the “Company”) announces its financial results for the three and nine months ended December 31, 2020.Quarterly Performance(1)   Non-IFRS financial measures are defined in the “Non-IFRS Financial Measures” section.Commentary on Quarterly PerformanceCMG’s Response to the COVID-19 PandemicThe COVID-19 pandemic and the related economic uncertainty negatively impacted our financial results for the three and nine months ended December 31, 2020, as some of our customers, faced with the economic uncertainly and decreasing commodity prices, curtailed spending and chose not to renew their licensing agreements or to renew them at reduced levels. These factors continue to contribute to a decrease in software license revenue during the three and nine months...

Continue reading

Amarin Provides Update on VASCEPA® (Icosapent Ethyl) Regulatory Review Processes in Mainland China and Hong Kong

DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that its corporate partner in China, Edding, has progressed VASCEPA® (icosapent ethyl) into commencement of the regulatory review processes in Mainland China and Hong Kong.In Mainland China, the Chinese National Medical Products Administration (NMPA) has accepted for review the new drug application (NDA) for VASCEPA. Edding is seeking labeling based on the entirety of clinical data available for VASCEPA, including the previously announced successful results of the Phase 3 study conducted by Edding as well as studies conducted by Amarin. Edding currently anticipates receiving a decision in Mainland China near the end of 2021.In Hong Kong, on a separate track, the Hong Kong Department of Health is evaluating...

Continue reading

Harfang reports gold-rich soil samples and commenced drilling at Serpent (James Bay, Québec)

MONTREAL, Feb. 09, 2021 (GLOBE NEWSWIRE) — Harfang Exploration Inc. (“Harfang”) (TSX-V: HAR) is pleased to announce new results from soil and infill till surveys completed on its 100% owned Serpent Property (“Property”) in James Bay (Québec) (Fig. 1). These highly encouraging results further reinforce gold potential in the bedrock in the vicinity of the previously disclosed gold-in-till anomaly. An Induced Polarization (“IP”) geophysical survey and a drill campaign are underway.HighlightsSoil survey defines priority targets (Fig. 2):35 samples (among 560 fine fraction, B-horizon samples) returned over 50 ppb Au and 17 returned more than 100 ppb Au. One soil sample graded up to 1.54 g/t Au in the vicinity of the interpreted Stu structure;Soil anomalies are distributed in 7 clusters (A to G) scattered over a 2.5 km by 1 km area along...

Continue reading

Harfang obtient des échantillons de sol fortement aurifères et a commencé à forer sur Serpent (Baie-James, Québec)

MONTRÉAL, 09 févr. 2021 (GLOBE NEWSWIRE) — Harfang Exploration Inc. (“Harfang”) (TSX-V: HAR) est fière d’annoncer de nouveaux résultats concernant des levés de sol et de till de définition sur sa propriété Serpent (« Propriété ») qu’elle détient à 100% à la Baie-James (Québec) (Fig. 1). Ces résultats très encourageants appuient davantage le potentiel en or des roches dans le secteur de l’anomalie aurifère dans les tills, annoncée précédemment. Un levé de géophysique de polarisation provoquée (« PP ») et une campagne de forage sont en cours.Faits saillantsLe levé de sol définit des cibles prioritaires (Fig. 2):35 échantillons (parmi 560 échantillons d’horizon B [fraction fine]) ont donné plus de 50 ppb Au et 17 d’entre eux ont donné plus de 100 ppb Au. Un échantillon de sol pris à proximité de la structure interprétée Stu a donné...

Continue reading

Plug Power’s $2B+ Capital Raise Marks the Largest Bought Deal in the CleanTech Sector

LATHAM, N.Y., Feb. 09, 2021 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of hydrogen engines and fueling solutions enabling e-mobility, today announced the completion of its previously announced upsized offering of 32,200,000 shares, which includes the underwriters option to purchase an additional 4,200,000 of its common stock. The shares were sold at a price to the public of $65 per share with net proceeds in excess of $2B. This transaction signifies the largest bought deal in the cleantech sector. This offering represents the third largest follow-on primary block trade with Morgan Stanley as a sole bookrunner in any market sector historically. Proceeds from this transaction, and final closing of the partnership with SK Group, will bring the total cash balance to over $5B. This liquidity positions Plug...

Continue reading

Kratos Defense Robotic Self-Driving Unmanned Truck Customer Portfolio Expands as Deployments are Increasing in the United States and Worldwide

SAN DIEGO, Feb. 09, 2021 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that with the November 2020 deployment in North Dakota, the Unmanned Systems Division has now deployed its self-driving truck, known as the Autonomous Truck Mounted Attenuator (ATMA), in eight locations across the United States and the UK. The success of the ATMA in increasing worker safety has sparked significant interest in the highway maintenance industry leading to a 9th deployment already under contract for this summer and targeted opportunities in 26 additional States for near-term deployments.A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4aa7172f-0acc-412b-a237-74198816a061In the commercial highway...

Continue reading

Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis

WIXOM, Mich., Feb. 09, 2021 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that Triferic AVNU (ferric pyrophosphate citrate injection), the intravenous (IV) formulation of Triferic, is now available to patients in the United States. Triferic AVNU was approved by the U.S. Food and Drug Administration (FDA) in March 2020 and is indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (HDD-CKD).“The commercial availability of Triferic AVNU is good news for patients with chronic kidney disease on hemodialysis and their healthcare providers. This IV formulation is an important...

Continue reading

Monopar Announces Issuance of Patent Covering Composition of Matter for MNPR-101 in Canada

WILMETTE, Ill., Feb. 09, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life and improve the quality of life for cancer patients, today announced the issuance of a patent covering composition of matter for MNPR-101 in Canada, adding to its existing protection in key markets around the world including the US, Europe and Japan.“This is an important advancement in our efforts to broaden our global patent estate for MNPR-101,” said Chandler Robinson, MD, Chief Executive Officer of Monopar. “MNPR-101 is a novel, first-in-class humanized monoclonal antibody to the urokinase Plasminogen Activator Receptor (uPAR). uPAR is a well credentialed target that appears to be overexpressed in certain aberrantly...

Continue reading

Green Thumb Industries Announces Initial Public Offering in the U.S. to Raise US$100,000,000

First Public Sale of Equity Registered with the U.S. Securities Exchange Commission by Green Thumb IndustriesCHICAGO and VANCOUVER, British Columbia, Feb. 09, 2021 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb”) (CSE: GTII) (OTCQX: GTBIF), a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, today announced that its Form S-1 registration statement relating to the potential sale of up to 10,000,000 of its subordinate voting shares (the “Registration Statement”), has been declared effective by the U.S. Securities and Exchange Commission (the “SEC”) as of February 8, 2021. Shortly following becoming effective, Green Thumb received and accepted an offer from a single institutional investor to purchase approximately 3.1 million registered subordinate voting shares at $32.03 per share for...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.